— Know what they know.
Not Investment Advice

HELP NASDAQ

Cybin Inc. Common Stock
1W: -7.2% 1M: -2.1% 3M: +98.6% YTD: +41.3%
$11.70
-0.21 (-1.76%)
 
Weekly Expected Move ±11.8%
$9 $10 $12 $13 $14
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 43 · $725.2M mcap · 49M float · 3.24% daily turnover · Short 45% of daily vol

Balance Sheet Trends

Total Assets
$252M -2.6% ▼
Total Liabilities
$19M -9.2% ▼
Shareholders Equity
$232M -2.1% ▼
Cash & Investments
$158M +16.9% ▲
Total Debt
$0 +0.0% ▲
Net Debt
-$158M -16.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2025FY2026
— Assets —
Cash$135M$158M
Short-Term Investments$0$0
Cash & ST Investments$135M$158M
Net Receivables$6M$5M
Inventory$0$0
Other Current Assets$3M$0
Total Current Assets$166M$185M
Property, Plant & Equip.$141K$196K
Goodwill & Intangibles$93M$67M
Long-Term Investments$0$0
Other Non-Current Assets$0$0
Total Non-Current Assets$93M$67M
Total Assets$259M$252M
— Liabilities —
Accounts Payable$21M$0
Short-Term Debt$0$0
Deferred Revenue$0$0
Other Current Liabilities$0$19M
Total Current Liabilities$21M$19M
Long-Term Debt$0$0
Other Non-Current Liab.$0$0
Total Non-Current Liabilities$0$0
Total Liabilities$21M$19M
— Equity —
Common Stock$464M$494M
Retained Earnings-$339M-$391M
Accumulated OCI-$7M$8M
Total Stockholders Equity$237M$232M
Total Liabilities & Equity$259M$252M
— Key Metrics —
Total Debt$0$0
Net Debt-$135M-$158M
Total Investments$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms